However, a more detailed study by Reitman et al. [21], who profiled >200 metabolites in IDH1- or IDH2-mut oligodendroglioma cells, detected changes in levels of amino acids, glutathione metabolites, choline derivatives, and tricarboxylic acid cycle intermediates. The gene discussed is IDH1; the disease is oligodendroglioma.